SLNO

39.49

6.76% 2.50

Dopo l'orario di chiusura: 39.64 0.15 +0.38%

Soleno Therapeutics Inc (SLNO)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$36.99

Aprire:

$36.25

Volume 24 ore:

3.57M

Relative Volume:

2.16

Capitalizzazione di mercato:

$2.04B

Reddito:

$190.41M

Utile/perdita netta:

$20.48M

Rapporto P/E:

177.24

EPS:

0.2228

Flusso di cassa netto:

$46.66M

1 W Prestazione:

+23.95%

1M Prestazione:

+1.10%

6M Prestazione:

-31.89%

1 anno Prestazione:

-46.40%

Intervallo 1D:

$36.00

$40.08

Intervallo di 1 settimana:

$29.43

$40.08

Portata 52W:

$29.43

$90.32

Soleno Therapeutics Inc Stock (SLNO) Company Profile

Nome

Soleno Therapeutics Inc

Settore

Healthcare (1118)

Industria

Biotechnology (624)

Telefono

650-213-8444

Indirizzo

100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA

Dipendente

182

Cinguettio

Prossima data di guadagno

2024-11-05

Ultimi documenti SEC

SLNO's Discussions on Twitter

Compare SLNO vs VRTX, REGN, ARGX, ALNY, INSM

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
SLNO Soleno Therapeutics Inc	39.49	2.04B	190.41M	20.48M	46.66M	0.2228
VRTX Vertex Pharmaceuticals Inc	438.71	111.45B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	761.85	80.54B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	746.42	46.32B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	318.85	42.29B	3.71B	313.75M	465.38M	2.2571
INSM Insmed Inc	162.43	35.01B	606.42M	-1.28B	-997.58M	-6.403

Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-11-18	Iniziato	Wolfe Research	Outperform
2025-10-07	Iniziato	Goldman	Buy
2025-08-20	Iniziato	Wells Fargo	Overweight
2025-06-23	Iniziato	TD Cowen	Buy
2025-03-05	Ripresa	Stifel	Buy
2024-12-02	Reiterato	Robert W. Baird	Outperform
2024-12-02	Reiterato	Stifel	Buy
2024-09-03	Iniziato	H.C. Wainwright	Buy
2024-05-10	Iniziato	Robert W. Baird	Outperform
2024-02-05	Iniziato	Piper Sandler	Overweight
2024-01-23	Iniziato	Stifel	Buy
2023-11-21	Ripresa	Guggenheim	Buy
2020-09-29	Iniziato	Guggenheim	Buy
2020-01-10	Iniziato	Craig Hallum	Buy
2019-12-23	Iniziato	Oppenheimer	Outperform
2018-02-13	Reiterato	Maxim Group	Buy

Mostra tutto

Soleno Therapeutics Inc Borsa (SLNO) Ultime notizie

08:13 AM

Soleno Therapeutics (SLNO) still appears attractive despite slower US launch ramp projections - MSN

08:13 AM

Apr 04, 2026

Do Ongoing DCCR Lawsuits Reframe Soleno Therapeutics’ (SLNO) Risk Profile More Than Its Drug Potential? - simplywall.st

Apr 04, 2026

SLNO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Soleno Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - accessnewswire.com

Apr 04, 2026

SLNO INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026 - Sahm

Apr 04, 2026

Apr 03, 2026

Soleno Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Soleno Therapeutics, Inc.SLNO - PR Newswire

Apr 03, 2026

Soleno Therapeutics Faces Lawsuit After DCCR Launch Setback and Share Drop - National Today

Apr 03, 2026

SLNO INVESTOR ALERT: Soleno (SLNO) Sued After DCCR Launch Setback, Share Drop-- Hagens Berman - ChartMill

Apr 03, 2026

Soleno Therapeutics Investors Eligible to Lead Securities Fraud Lawsuit - National Today

Apr 03, 2026

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Soleno Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLNO - GlobeNewswire Inc.

Apr 03, 2026

SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire

Apr 03, 2026

Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action LawsuitContact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - accessnewswire.com

Apr 03, 2026

Banque Pictet & Cie SA Takes $2.03 Million Position in Soleno Therapeutics, Inc. $SLNO - MarketBeat

Apr 03, 2026

H.C. Wainwright cuts Soleno Therapeutics stock price target to $100 - Investing.com

Apr 03, 2026

Apr 02, 2026

Soleno Therapeutics Faces Class Action Lawsuit Over Drug Trial Concerns - National Today

Apr 02, 2026

Class Action Lawsuit Filed Against Soleno Therapeutics Over DCCR Disclosures - Intellectia AI

Apr 02, 2026